FDA Clears Tris Pharma’s Onyda XR for ADHD: A Daily, Long-Acting Oral Liquid Medication Frank Dolan May 30, 2024
FDA Accelerates Review of Keytruda Combo as Initial Therapy for Inoperable Advanced or Metastatic Malignant Pleural Mesothelioma. Frank Dolan May 29, 2024
Johnson & Johnson Secures Numab’s Experimental Antibody for Atopic Dermatitis Treatment. Frank Dolan May 28, 2024
Streamlining Clinical Trials: Strategies for Efficiency in Modern Medical Research Arsenal May 28, 2024
Felzartamab Shows Promise for Late Antibody-Mediated Kidney Transplant Rejection Arsenal May 27, 2024
Degron Therapeutics and Takeda Sign an Exclusive License and Partnership Deal to Create Molecule Degraders for Various Medical Conditions Frank Dolan May 24, 2024
FDA Greenlights Phase III Study Protocol for Combination of Laekna’s LAE002 and LAE001 in Treating Prostate Cancer. Frank Dolan May 23, 2024
2024 US Pharmaceutical and Biotechnology Conference: Enhancing Health Policies Post-Election. Frank Dolan May 22, 2024
